Precigen (PGEN) Interest & Investment Income (2012 - 2026)
Precigen (PGEN) reported Interest & Investment Income of $683000.0 for Q1 2026, down 25.6% year-over-year from $918000.0 in Q1 2025, and down 35.99% quarter-over-quarter from $1.1 million in Q4 2025.
Precigen (PGEN) Interest & Investment Income (2012 - 2026) Analysis & Trends
Precigen (PGEN) has 15 years of Interest & Investment Income data on file, last reported at $683000.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $683000.0, down 25.6% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.0 million (up 72.45% YoY), and the FY2025 annual result was $3.2 million, up 126.73% from the prior year.
- Interest & Investment Income slipped to $683000.0 in Q1 2026 per PGEN's latest filing, from $1.1 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.1 million in Q4 2025 and troughed at $2000.0 in Q4 2022.
- A 5-year average of $511000.0 and a median of $608000.0 in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2022 and 2023: Interest & Investment Income plunged 95.24% in 2022, then jumped 45950.0% in 2023.
- A 5-year view of Interest & Investment Income shows it stood at $2000.0 in 2022, then jumped by 45950.0% to $921000.0 in 2023, then plunged by 77.42% to $208000.0 in 2024, then soared by 412.98% to $1.1 million in 2025, then slumped by 35.99% to $683000.0 in 2026.
- Business Quant data shows PGEN's Interest & Investment Income at $683000.0 in Q1 2026, $1.1 million in Q4 2025, and $534000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -14.79 Mn |
| 10 | Precigen | 1.38 Bn | 1.38 Bn | 20.69 Mn | 683,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 683,000.00 |
| Dec 31, 2025 | 1.07 Mn |
| Sep 30, 2025 | 534,000.00 |
| Jun 30, 2025 | 696,000.00 |
| Mar 31, 2025 | 918,000.00 |
| Dec 31, 2024 | 208,000.00 |
| Sep 30, 2024 | 283,000.00 |
| Jun 30, 2024 | 319,000.00 |
| Mar 31, 2024 | 608,000.00 |
| Dec 31, 2023 | 921,000.00 |
| Sep 30, 2023 | 856,000.00 |
| Jun 30, 2023 | 828,000.00 |
| Mar 31, 2023 | 633,000.00 |
| Dec 31, 2022 | 2,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 38,000.00 |
| Dec 31, 2021 | 42,000.00 |
| Sep 30, 2021 | 48,000.00 |
| Jun 30, 2021 | 49,000.00 |